Borghetti, Paolo <br/><br/>
Concomitant radiotherapy and TKI in metastatic EGFR- or ALK-mutated non-small cell lung cancer: a multicentric analysis on behalf of AIRO lung cancer study group.  [electronic resource] 

 -  La Radiologia medica  Jul 2019 
 - 662-670 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>1826-6983 
<br/><br/><label>Standard No.: </label>10.1007/s11547-019-00999-w  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Anaplastic Lymphoma Kinase--genetics<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Combined Modality Therapy<br/>DNA Mutational Analysis<br/>ErbB Receptors--genetics<br/>Female<br/>Humans<br/>Italy<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Mutation<br/>Neoplasm Metastasis<br/>Protein Kinase Inhibitors--therapeutic use<br/>Retrospective Studies<br/>Societies, Medical<br/>Survival Rate<br/>Treatment Outcome